Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

v3.22.2.2
Stockholders’ Equity (Details Narrative)
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jul. 02, 2022
shares
Mar. 26, 2021
shares
Mar. 31, 2022
$ / shares
shares
Mar. 31, 2021
USD ($)
$ / shares
shares
Feb. 28, 2021
shares
Jan. 31, 2021
USD ($)
$ / shares
shares
Jan. 31, 2020
$ / shares
shares
Sep. 30, 2022
USD ($)
$ / shares
shares
Sep. 30, 2021
USD ($)
shares
Sep. 30, 2022
USD ($)
$ / shares
shares
Sep. 30, 2021
USD ($)
shares
Dec. 31, 2021
$ / shares
shares
May 24, 2021
shares
Mar. 25, 2021
shares
Subsidiary, Sale of Stock [Line Items]                            
Common stock, shares authorized   24,000,000   12,000,000       24,000,000   24,000,000   24,000,000 12,000,000 12,000,000
Common stock issued during period           1,711,783                
Share price per share | $ / shares           $ 3.00                
Proceeds from public offering | $           $ 4,532,445                
Warrants to purchase shares of common stock   2,190,000       136,943                
Warrant term           5 years                
Warrant exercise price | $ / shares           $ 3.75                
Number of shares, warrants exercised                     495,641    
Warrants exercisable date   May 24, 2021                        
Preferred stock, shares authorized               10,000,000   10,000,000   10,000,000    
Preferred stock, par value | $ / shares               $ 0.001   $ 0.001   $ 0.001    
Preferred stock, shares issued               465   465   465    
Preferred stock, shares outstanding               465   465   465    
Number of shares granted                   433,973   698,831    
Allocation share based compensation expense | $               $ 275,418 $ 659,512 $ 613,833 $ 893,431      
Option exercise price | $ / shares                   $ 0.815        
Stock options compensation cost | $               $ 908,588   $ 908,588        
Weighted average remaining recognition period                   2 years        
Directors [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Number of shares granted     56,000                      
Option strike price | $ / shares     $ 2.50         $ 2.50   $ 2.50        
Vesting percentage                   75.00%        
Directors [Member] | December 31, 2022 [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Vesting percentage                   25.00%        
Twelve Employees [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Number of shares granted                   228,973        
President and CEO [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Number of shares granted                   135,000        
Option strike price | $ / shares               2.50   $ 2.50        
Common shares granted for the period 194,940   30,000             406,887        
President and CEO [Member] | Minimum [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Option exercise price | $ / shares                   $ 1.30        
President and CEO [Member] | Maximum [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Option exercise price | $ / shares                   $ 2.50        
President and CEO [Member] | March 15, 2025 [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Common shares granted for the period                   181,947        
Two Consultants [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Number of shares granted                   14,000        
Option strike price | $ / shares               $ 2.50   $ 2.50        
Fifteen Employees [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Common shares granted for the period                   404,975        
Fifteen Employees [Member] | Minimum [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Option exercise price | $ / shares                   $ 1.30        
Fifteen Employees [Member] | Maximum [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Option exercise price | $ / shares                   $ 2.50        
Consultant [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Option exercise price | $ / shares     $ 2.50                      
Common shares granted for the period     3,000                      
2013 Stock Option Plan [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Common stock shares reserved for issuance               450,617   450,617        
2020 Stock Appreciation Rights Plan [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Option exercise price | $ / shares                   $ 0.815        
Unrecognized share based compensation cost | $               $ 1,128,615   $ 1,128,615        
Weighted average remaining recognition period                   2 years 4 months 17 days        
Investor [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Share price per share | $ / shares       $ 4.99                    
Stock issued during the period, service rendered       1,500                    
April 2020 Offering [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Common stock issued during period       21,591                    
Number of shares, warrants exercised       191,204                    
Placement Agent Warrants [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Warrants to purchase shares of common stock       175,200                    
Warrant exercise price | $ / shares       $ 5.55625                    
Percentage of warrant exercise price       8                    
Placement Agent Warrants [Member] | Measurement Input, Share Price [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Percentage of warrant exercise price       125                    
Common Stock [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Common stock issued during period                     3,901,783      
Stock issued during the period, service rendered                   1,500      
Series D Convertible Preferred Stock [Member] | Common Stock [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Common stock issued during period       119,000                    
Conversion of stock shares converted       250                    
Number of shares as in-kind payment, shares       19,000                    
Series D Preferred Stock [Member] | Institutional Securities Purchase Agreement [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Common stock issued during period                   87,267        
Preferred stock, par value | $ / shares             $ 1,000              
Preferred stock, shares outstanding               132   132        
Sale of shares             1,640              
Dividend percentage             9.00%              
Conversion price per share | $ / shares             $ 2.50              
Conversion description             Alternatively, a holder may at any time convert all, or any part, of its Series D Preferred Shares at an alternative conversion price equal to the lower of the applicable conversion price then in effect, and the greater of (x) $1.80 and (y) 85% of the average volume weighted average price (“VWAP”) of the Common Stock for a five-trading day period prior to such conversion. Upon the occurrence of certain triggering events, described in the Certificate of Designations, including, but not limited to payment defaults, breaches of transaction documents, failure to maintain listing on the Nasdaq Capital Market, and other defaults set forth therein, the Series D Preferred Shares would become subject to redemption, at the option of a holder, at a 125% premium to the underlying value of the Series D Preferred Stock being redeemed              
Series E Preferred Stock [Member] | Institutional Securities Purchase Agreement [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Common stock issued during period                   61,651        
Conversion of stock shares converted                   48,544        
Preferred stock, par value | $ / shares               $ 1,000   $ 1,000        
Preferred stock, shares outstanding               333   333        
Sale of shares                   333        
Dividend percentage                   9.00%        
Private Placement [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Common stock issued during period         263,200                  
Private Placement [Member] | Purchase Agreement [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Warrants to purchase shares of common stock       2,190,000                    
Warrant exercise price | $ / shares       $ 4.32                    
Public Offering [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Common stock issued during period       2,190,000                    
Share price per share | $ / shares       $ 4.445                    
Proceeds from public offering | $       $ 8,736,487